Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive diabetes screening study opens doors to future treatments

NCT ID NCT07606066

Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 26, 2026 · Updated 4 times

Summary

This study is recruiting 3,000 adults with type 2 diabetes to collect basic health information and a small blood sample. The goal is to identify people who may be eligible for other clinical trials. No experimental treatment is given. Participants simply help researchers understand patient characteristics and medication use across different regions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study will help match people with type 2 diabetes to future clinical trials more efficiently, speeding up research.
What could go wrong
This is not a treatment study—it only collects data and blood samples. There is no direct health benefit for participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,150 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults with Type 2 Diabetes

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must be ≥ 18 years of age at the time of signing the ICF. * Patients with a diagnosis of T2DM, test- or documentation-confirmed as per World Health Organization or local diagnostic standards, inadequately managed with: 1. Lifestyle management alone, AND/OR 2. A stable dose of background glucose-lowering medication(s) for T2DM (As specified in the Protocol) for at least 45 days prior to signing the ICF. * Expresses interest in participating in an ongoing or future T2DM clinical study, is motivated and willing to make themselves available for the duration of the study, and is able to follow study procedures as required. * Provision of signed and dated written informed consent (As specified in the Protocol) before any study-specific procedures, sampling, or analysis. Exclusion Criteria: * Current or planned use of GLP-1 RAs prohibited in ongoing or future T2DM studies evaluating the efficacy and safety of investigational GLP-1 RAs (As specified in the Protocol). * Diagnosed with Type 1 diabetes mellitus. * Known pregnancy at the time of visit or having the intention to become pregnant.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    75 sites in 7 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Research Site

    NOT_YET_RECRUITING

    Peoria, Arizona, 85382, United States

  • Research Site

    RECRUITING

    Little Rock, Arkansas, 72205, United States

  • Research Site

    RECRUITING

    Lincoln, California, 95648, United States

  • Research Site

    NOT_YET_RECRUITING

    Jacksonville, Florida, 32256, United States

  • Research Site

    RECRUITING

    Lake City, Florida, 32055, United States

  • Research Site

    NOT_YET_RECRUITING

    Leesburg, Florida, 34748, United States

  • Research Site

    RECRUITING

    Ocoee, Florida, 34761, United States

  • Research Site

    RECRUITING

    Decatur, Georgia, 30030, United States

  • Research Site

    NOT_YET_RECRUITING

    Melrose Park, Illinois, 60160, United States

  • Research Site

    NOT_YET_RECRUITING

    El Dorado, Kansas, 67042, United States

  • Research Site

    RECRUITING

    Potomac, Maryland, 20854, United States

  • Research Site

    NOT_YET_RECRUITING

    Maumee, Ohio, 43537, United States

  • Research Site

    RECRUITING

    Gaffney, South Carolina, 29340, United States

  • Research Site

    RECRUITING

    Renton, Washington, 98057, United States

  • Research Site

    NOT_YET_RECRUITING

    Fortaleza, Ceará, 60430-350, Brazil

  • Research Site

    RECRUITING

    Curitiba, Paraná, 80030-480, Brazil

  • Research Site

    NOT_YET_RECRUITING

    Natal, Rio Grande do Norte, 59020-035, Brazil

  • Research Site

    NOT_YET_RECRUITING

    Porto Alegre, Rio Grande do Sul, 90630-165, Brazil

  • Research Site

    NOT_YET_RECRUITING

    Campinas, São Paulo, 13060-904, Brazil

  • Research Site

    NOT_YET_RECRUITING

    São José dos Campos, São Paulo, 12243-280, Brazil

  • Research Site

    NOT_YET_RECRUITING

    São Paulo, São Paulo, 01228-200, Brazil

  • Research Site

    NOT_YET_RECRUITING

    São Paulo, São Paulo, 04012-180, Brazil

  • Research Site

    NOT_YET_RECRUITING

    Barretos, 14784-400, Brazil

  • Research Site

    NOT_YET_RECRUITING

    Brasília, 71625-009, Brazil

  • Research Site

    NOT_YET_RECRUITING

    Rio de Janeiro, 22270-060, Brazil

  • Research Site

    RECRUITING

    Budapest, HU, 1036, Hungary

  • Research Site

    RECRUITING

    Budapest, HU, 1089, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Debrecen, HU, 4032, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Szeged, HU, 6725, Hungary

  • Research Site

    RECRUITING

    Budapest, 1024, Hungary

  • Research Site

    RECRUITING

    Budapest, 1132, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Budapest, 1138, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Salgótarján, 3100, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Szolnok, 5000, Hungary

  • Research Site

    RECRUITING

    Zalaegerszeg, 8900, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Guntur, Andhra Pradesh, 522001, India

  • Research Site

    NOT_YET_RECRUITING

    Guwahati, Assam, 781032, India

  • Research Site

    NOT_YET_RECRUITING

    Bangalore, Karnataka, 560092, India

  • Research Site

    NOT_YET_RECRUITING

    Belagavi, Karnataka, 590006, India

  • Research Site

    NOT_YET_RECRUITING

    Belagavi, Karnataka, 590010, India

  • Research Site

    NOT_YET_RECRUITING

    Calicut, Kerala, 673008, India

  • Research Site

    NOT_YET_RECRUITING

    Kochi, Kerala, 682041, India

  • Research Site

    NOT_YET_RECRUITING

    Thiruvananthapuram, Kerala, 695031, India

  • Research Site

    NOT_YET_RECRUITING

    Indore, Madhya Pradesh, 452008, India

  • Research Site

    NOT_YET_RECRUITING

    Mumbai, Maharashtra, 400012, India

  • Research Site

    NOT_YET_RECRUITING

    Nagpur, Maharashtra, 440010, India

  • Research Site

    NOT_YET_RECRUITING

    Pune, Maharashtra, 411013, India

  • Research Site

    NOT_YET_RECRUITING

    Pune, Maharashtra, 411021, India

  • Research Site

    NOT_YET_RECRUITING

    Delhi, New Delhi, 110029, India

  • Research Site

    NOT_YET_RECRUITING

    Jaipur, Rajasthan, 302017, India

  • Research Site

    NOT_YET_RECRUITING

    Chennai, Tamil Nadu, 600086, India

  • Research Site

    NOT_YET_RECRUITING

    Coimbatore, Tamil Nadu, 641018, India

  • Research Site

    NOT_YET_RECRUITING

    Lucknow, Uttar Pradesh, 226030, India

  • Research Site

    NOT_YET_RECRUITING

    Kolkata, West Bengal, 700020, India

  • Research Site

    RECRUITING

    Seremban, Negeri Sembilan, 70300, Malaysia

  • Research Site

    NOT_YET_RECRUITING

    Seri Manjung, Perak, 32040, Malaysia

  • Research Site

    WITHDRAWN

    Batu Caves, Selangor, 68100, Malaysia

  • Research Site

    NOT_YET_RECRUITING

    Kuala Lumpur, Wilayah Persekutuan Kuala Lump, 59100, Malaysia

  • Research Site

    NOT_YET_RECRUITING

    Putrajaya, 62250, Malaysia

  • Research Site

    NOT_YET_RECRUITING

    Lublin, Lublin Voivodeship, 20-718, Poland

  • Research Site

    NOT_YET_RECRUITING

    Krakow, Malopolska, 31-261, Poland

  • Research Site

    NOT_YET_RECRUITING

    Radom, Masovian Voivodeship, 26-600, Poland

  • Research Site

    RECRUITING

    Bialystok, Podlaskie Voivodeship, 15-879, Poland

  • Research Site

    NOT_YET_RECRUITING

    Częstochowa, Silesian Voivodeship, 42-217, Poland

  • Research Site

    RECRUITING

    Poznan, 60-354, Poland

  • Research Site

    NOT_YET_RECRUITING

    Warsaw, 00-124, Poland

  • Research Site

    RECRUITING

    Lodz, Łódź Voivodeship, 90-338, Poland

  • Research Site

    NOT_YET_RECRUITING

    Kielce, Świętokrzyskie Voivodeship, 25-355, Poland

  • Research Site

    RECRUITING

    Ankara, Turkey, 6100, Turkey (Türkiye)

  • Research Site

    NOT_YET_RECRUITING

    Adana, 01060, Turkey (Türkiye)

  • Research Site

    NOT_YET_RECRUITING

    Adana, 01250, Turkey (Türkiye)

  • Research Site

    NOT_YET_RECRUITING

    Ankara, 06530, Turkey (Türkiye)

  • Research Site

    NOT_YET_RECRUITING

    Gaziantep, 27470, Turkey (Türkiye)

  • Research Site

    NOT_YET_RECRUITING

    Istanbul, 34265, Turkey (Türkiye)

  • Research Site

    NOT_YET_RECRUITING

    Istanbul, 34384, Turkey (Türkiye)

  • Research Site

    NOT_YET_RECRUITING

    Kayseri, 38039, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.